PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+5.38%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.64B
AUM Growth
-$53.3M
(-2%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
36.54%
Holding
1,168
New
94
Increased
480
Reduced
555
Closed
36
Top Buys
| 1 |
Apple
AAPL
|
+$4.55M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1.79M |
| 3 |
ConocoPhillips
COP
|
+$1.73M |
| 4 |
Insmed
INSM
|
+$1.69M |
| 5 |
Super Micro Computer
SMCI
|
+$1.63M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$51.6M |
| 2 |
Microsoft
MSFT
|
+$20.2M |
| 3 |
Broadcom
AVGO
|
+$9.75M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.72M |
| 5 |
Amazon
AMZN
|
+$5.69M |
Sector Composition
| 1 | Technology | 43.4% |
| 2 | Healthcare | 11.97% |
| 3 | Consumer Discretionary | 10.33% |
| 4 | Communication Services | 9.11% |
| 5 | Financials | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Ameriprise Financial
AMP
$46.4B
| $729K | 0.03% |
1,551
+54
| +4% | +$25.4K |
|
402
Denali Therapeutics
DNLI
$2.14B
| $724K | 0.03% |
24,858
-4,515
| -15% | -$132K |
|
403
MSCI
MSCI
$43.6B
| $722K | 0.03% |
1,238
+41
| +3% | +$23.9K |
|
404
Norfolk Southern
NSC
$61.1B
| $720K | 0.03% |
2,897
-648
| -18% | -$161K |
|
405
XPeng
XPEV
$19.1B
| $720K | 0.03% |
59,104
-2,132
| -3% | -$26K |
|
406
Agilent Technologies
A
$35.2B
| $718K | 0.03% |
4,834
+380
| +9% | +$56.4K |
|
407
Prudential Financial
PRU
$37.2B
| $714K | 0.03% |
5,892
+671
| +13% | +$81.3K |
|
408
Equity Residential
EQR
$25.2B
| $712K | 0.03% |
9,562
+4,222
| +79% | +$314K |
|
409
SBA Communications
SBAC
$20.8B
| $711K | 0.03% |
2,954
+1,246
| +73% | +$300K |
|
|
CHX
410
DELISTED
ChampionX
CHX
| $706K | 0.03% |
23,410
-4,549
| -16% | -$137K |
|
411
LyondellBasell Industries
LYB
$17.5B
| $702K | 0.03% |
7,322
+1,009
| +16% | +$96.8K |
|
412
Sanofi
SNY
$115B
| $701K | 0.03% |
12,172
-1,835
| -13% | -$106K |
|
413
ASE Group
ASX
$24.6B
| $701K | 0.03% |
71,791
-8,181
| -10% | -$79.8K |
|
414
Myriad Genetics
MYGN
$642M
| $700K | 0.03% |
25,574
+4,434
| +21% | +$121K |
|
415
Rhythm Pharmaceuticals
RYTM
$6.66B
| $700K | 0.03% |
13,358
-617
| -4% | -$32.3K |
|
416
M&T Bank
MTB
$31B
| $696K | 0.03% |
3,908
+656
| +20% | +$117K |
|
417
Vera Therapeutics
VERA
$1.55B
| $696K | 0.03% |
15,746
-6,650
| -30% | -$294K |
|
418
Kenvue
KVUE
$35.4B
| $695K | 0.03% |
30,028
+7,955
| +36% | +$184K |
|
419
Weyerhaeuser
WY
$18.1B
| $690K | 0.03% |
20,384
+9,091
| +81% | +$308K |
|
|
SW
420
Smurfit Westrock plc
SW
$23.6B
| $686K | 0.03% |
+13,888
| New | +$686K |
|
421
AngloGold Ashanti
AU
$32.6B
| $685K | 0.03% |
25,731
-5,994
| -19% | -$160K |
|
422
Viatris
VTRS
$11.9B
| $682K | 0.03% |
58,770
-3,821
| -6% | -$44.4K |
|
423
Fifth Third Bancorp
FITB
$30.1B
| $677K | 0.03% |
15,794
+2,521
| +19% | +$108K |
|
424
Johnson Controls International
JCI
$70.5B
| $664K | 0.03% |
8,557
-2,014
| -19% | -$156K |
|
425
Mirum Pharmaceuticals
MIRM
$3.76B
| $662K | 0.03% |
16,984
+3,976
| +31% | +$155K |
|